| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:11Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:58Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:53Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 國立成功大學 |
2022 |
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
|
Tseng, C.-W.;Liu, W.-C.;Chen, Chen C.-Y.;Chang, T.-T.;Tseng, K.-C. |
| 臺大學術典藏 |
2021-09-04T06:11:15Z |
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
|
Tseng K.-C.; Tseng C.-W.; Hsieh T.-Y.; Peng C.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:42Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-05-28T02:07:22Z |
Method for prognosis of gastric cancer
|
Juan, H.-F., Chen, C.-N., Tseng, C.-W., Chang, K.-J.; Juan, H.-F.; Chen, C.-N.; Tseng, C.-W.; Chang, K.-J. |
| 臺大學術典藏 |
2021-05-27T02:50:12Z |
Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker
|
Tseng C.-W.; JYH-CHIN YANG; Chen C.-N.; Huang H.-C.; Chuang K.-N.; Lin C.-C.; Lai H.-S.; Lee P.-H.; Chang K.-J.; Juan H.-F. |
| 臺大學術典藏 |
2021-05-24T07:20:20Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
CHEN-HUA LIU; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:13Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
CHEN-HUA LIU; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?�Y.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-06T01:25:13Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H. |
| 國立成功大學 |
2021 |
Stability Improvement of a DC Microgrid Fed to a Multimachine Power System Using a STATCOM
|
Wang, L.;Huang, Huang H.-S.;Lee, M.-F.;Lin, Y.-S.;Huang, Z.-H.;Gao, H.-Y.;Tseng, C.-W.;Tseng, C.-C.;Prokhorov, A.V.;Mokhlis, H.B.;Chua, K.H.;Tripathy, M. |
| 國立成功大學 |
2021 |
Small-Signal Stability Analysis of a Vanadium Redox Flow Battery-based Energy-Storage System
|
Wang, L.;Gao, H.-Y.;Tseng, C.-W.;Huang, Z.-H.;Lee, M.-F.;Lin, Y.-S.;Huang, Huang H.-S.;Tseng, C.-C.;Prokhorov, A.V.;Mokhlis, H.B.;Chua, K.H.;Tripathy, M. |
| 臺大學術典藏 |
2020-11-19T03:19:38Z |
Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker
|
Chuang K.-N.; Lin C.-C.; Lai H.-S.; PO-HUANG LEE; Chang K.-J.; Juan H.-F.; Tseng C.-W.;Yang J.-C.;Chen C.-N.;Huang H.-C.;Chuang K.-N.;Lin C.-C.;Lai H.-S.;Po-Huang Lee;Chang K.-J.;Juan H.-F.; Tseng C.-W.; Yang J.-C.; Chen C.-N.; Huang H.-C. |
| 臺大學術典藏 |
2020-10-06T06:53:59Z |
Poster: Design and implementation of IoT-enable mobile E-learning platform for medical education
|
Wu M.-C.; CHENG-YI WU; Lien W.-C.; Kong Y.-K.; Tseng C.-W.; Lin P.; Chang C.-W. |
| 臺大學術典藏 |
2020-08-21T07:43:09Z |
HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin
|
Hung T.-H.; CHIN-KUO CHANG; Lai N.-S.; Hsieh Y.-H.; Tseng C.-W.; Tseng C.-W.;Hsieh Y.-H.;Chin-Kuo Chang;Lai N.-S.;Hung T.-H.;Wu S.-F.;Tseng K.-C.; Wu S.-F.; Tseng K.-C. |
| 臺大學術典藏 |
2020-08-21T07:43:07Z |
Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan
|
Chang T.-T.; Hung T.-H.; Lai N.-S.; CHIN-KUO CHANG; Hsieh Y.-H.; Tseng K.-C.;Tseng C.-W.;Hsieh Y.-H.;Chin-Kuo Chang;Lai N.-S.;Hung T.-H.;Chang T.-T.; Tseng K.-C.; Tseng C.-W. |
| 臺大學術典藏 |
2020-05-04T08:02:58Z |
Poster: Design and implementation of IoT-enable mobile E-learning platform for medical education
|
Chang, C.-W.;Lin, P.;Tseng, C.-W.;Kong, Y.-K.;Lien, W.-C.;Wu, M.-C.;Wu, C.-Y.; Chang, C.-W.; Lin, P.; Tseng, C.-W.; Kong, Y.-K.; Lien, W.-C.; Wu, M.-C.; Wu, C.-Y.; PHONE LIN |
| 臺大學術典藏 |
2020-05-04T08:02:57Z |
A scheduled grouping scheme for MTC device ID sharing
|
Tseng, C.-W.;Boisguene, R.;Huang, C.-W.;Lin, P.;Kawamoto, Y.; Tseng, C.-W.; Boisguene, R.; Huang, C.-W.; Lin, P.; Kawamoto, Y.; PHONE LIN |
| 臺大學術典藏 |
2020-04-21T03:52:07Z |
Evidence for a second-order phase transition around 350 K in Ce3Rh4Sn13
|
Kuo, C. N.; Chen, W. T.; Tseng, C. W.; Hsu, C. J.; Huang, R. Y.; Chou, F. C.; Kuo, Y. K.; Lue, C. S. |
| 臺大學術典藏 |
2020-02-27T07:42:56Z |
Acute paresthesia in a patient with migraine
|
WEN-JONE CHEN;Tsai K.-C.;Wu C.-C.;Tseng C.-W.; Tseng C.-W.; Wu C.-C.; Tsai K.-C.; WEN-JONE CHEN |
